(Q40484709)

20 September 2017

title

Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors (English)

1 reference

20 September 2017

1 reference

Aynur Oguz

1

1 reference

20 September 2017

Ceyda Karadeniz

2

1 reference

20 September 2017

Elvan Caglar Citak

3

1 reference

20 September 2017

Visal Cil

4

1 reference

20 September 2017

Nilufer Eldes

5

1 reference

20 September 2017

language of work or name

1 reference

1 April 2006

1 reference

Pediatric Hematology and Oncology

20 September 2017

published in

1 reference

20 September 2017

volume

23

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

245-253

1 reference

Empiric treatment of infection during granulocytopenia: a comprehensive approach

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Approaching the controversies in antibacterial management of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Ceftriaxone plus conventional or single-daily dose amikacin versus ceftazidime/amikacin as empiric therapy in febrile neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

A comparative study of cefepime versus ceftazidime as empiric therapy of febrile episodes in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Treatment of febrile neutropenia with cefepime monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Meropenem: a microbiological overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Can

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

Ceftriaxone versus imipenem/cilastatin as empirical monotherapy for infections in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506867

10.1080/08880010500506867

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference